Report - 慈濟藥訊 · 2017. 6. 15. · 慈濟藥訊(152)-3/9 =臨床藥學科整理= SGLT2 抑制劑類藥品含canagliflozin、dapagliflozin 及 empagliflozin 成分可能增 加腳趾截肢的潛在風險

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form